Effect of co-administration of ezetimibe/sinivastatin and fenofibrate on apolipoproteins (A-I, B, and CIII) in patients with mixed hyperlipidemia

被引：0
|
作者：
Famier, M.
Roth, E. M.
Perevozskaya, I. T.
Davies, M. J.
Kush, D.
Mitche, Y. B.
机构：
[1] Point Med, Dijon, France
[2] Sterling Res Grp, Cincinnati, OH USA
[3] Merck Res Labs, Rahway, NJ USA
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2007年 / 8卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：206 / 207
页数：2
相关论文
共 12 条
  • [1] Effect of co-administration of ezetimibe/simvastatin and fenofibrate on apolipoproteins (A-III, B, and C-III) in patients with mixed hyperlipidemia
    Roth, Eli
    Farnier, Michel
    Perevozskaya, Inna
    Davies, Michael
    Kush, Debra
    Mitchel, Yale
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (09) : 325A - 325A
  • [2] Safety and efficacy of long-term co-administration of fenofibrate and ezetimibe in patients with mixed hyperlipidemia
    McKenney, JM
    Farnier, M
    Lo, KW
    Bays, HE
    Perevozkaya, I
    Carlson, G
    Davies, MJ
    Mitchel, YB
    Gumbiner, B
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (08) : 1584 - 1587
  • [3] Effects of the co-administration of ezetimibe/simvastatine and fenofibrate on the lipoproteins sub-classes and on the LDL size profile in patients with mixed hyperlipidemia
    Farnier, M.
    Perevozskaya, I.
    Taggart, W.
    Kush, D.
    Mitchel, Y.
    DIABETES & METABOLISM, 2007, 33 : S59 - S60
  • [4] INFLUENCE OF EZETIMIBE AND CO-ADMINISTRATION OF EZETIMIBE/SIMVASTATIN ON POSTPRANDIAL HYPERLIPIDEMIA IN PATIENTS WITH PRIMARY HYPERLIPIDEMIA.
    Bubnova, M.
    Aronov, D.
    ATHEROSCLEROSIS, 2019, 287 : E205 - E205
  • [5] Efficacity and tolerance in the long-term of the co-administration of fenofibrate and ezetimibe in patients with mixed hyperlipidemy
    Farnier, M
    Mc Kenney, J
    Lo, KW
    Perevozskhaya, I
    Carlson, G
    Macdonell, G
    Davies, M
    Mitchel, Y
    Gumbiner, B
    DIABETES & METABOLISM, 2006, 32 : S37 - S38
  • [6] Effect of coadministered ezetimibe and fenofibrate on the atherogenic dyslipidemia in obese patients with mixed hyperlipidemia
    Davies, M
    Shah, A
    Macdonell, G
    Gumbiner, B
    OBESITY RESEARCH, 2005, 13 : A132 - A133
  • [7] Effect of Fenofibrate and Ezetimibe on lipoprotein subclasses and LDL subclass pattern in patients with mixed hyperlipidemia
    Tribble, D
    Farnier, M
    Freeman, MW
    Macdonell, G
    Perevozskaya, I
    Davies, MJ
    Gumbiner, B
    CIRCULATION, 2004, 110 (17) : 143 - 144
  • [8] Efficacy and safety of co-administered ezetimibe/simvastatin (EZE/SIMVA) and fenofibrate (FENO) in patients with mixed hyperlipidemia
    Farnier, M.
    Roth, E.
    Gil-Extremera, B.
    Mendez, G. F.
    Perevozskaya, I.
    Hamlin, C.
    Macdonell, G.
    Davies, M.
    Kush, D.
    Mitchel, Y.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 174 - 174
  • [9] Efficacy and safety of 6 months co-administration of ezetimibe plus rosuvastatin in patients with mixed dyslipidemia
    Styliadis, I. H.
    Boufidou, A.
    Makedou, A.
    Damvopoulou, E.
    Giannakoulas, G.
    Stefanidis, H.
    Parharidis, G. E.
    ATHEROSCLEROSIS SUPPLEMENTS, 2007, 8 (01) : 202 - 202
  • [10] Effects of co-administered ezetimibe/simvastatin and fenofibrate on lipoprotein subclasses and LDL size pattern in patients with mixed hyperlipidemia
    Farnier, M.
    Perevozskaya, I. T.
    Taggart, W. V.
    Kush, D.
    Mitchel, Y. B.
    ATHEROSCLEROSIS SUPPLEMENTS, 2007, 8 (01) : 209 - 210
12